EUVIMEDEUVIMED entdecken
Crossref

Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast Cancer

Guimei Li, Juping Tang, Lang Wang, Meng Wang, Yong Yang, Zhikun Liu, Hengshan Wang iD, Xiaochao Huang

Journal of Medicinal Chemistry · 2026

DOI: 10.1021/acs.jmedchem.6c00477 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicinal Chemistry, 2026. Verfasst von Guimei Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry a…. Hauptthemen laut MEDLINE: Prodrugs, Ferroptosis, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 74 Literaturangaben. Gefördert von: Huaiyin Institute of Technology, Natural Science Foundation of Guangxi Zhuang Autonomous Region, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Thioredoxin reductase (TrxR) serves as a therapeutic target for triple-negative breast cancer (TNBC) treatment owing to its overexpression in TNBC cells. Herein, a series of Pt(IV) prodrugs targeting both TrxR and DNA were designed and synthesized. The superior complex 6b demonstrated remarkable activity against both cisplatin-sensitive and -resistant TNBC cells and effectively inhibited TrxR1 both in vitro and in vivo. Moreover, complex 6b significantly induced ferroptosis through glutathione depletion, the accumulation of intracellular lipid peroxidation, and the deactivation of glutathione peroxidase 4, respectively. Notably, complex 6b induced an excessive accumulation of intracellular reactive oxygen species to trigger endoplasmic reticulum (ER) stress and subsequently induce immunogenic cell death. Overall, this study presents an innovative strategy for enhancing cisplatin sensitivity and overcoming cisplatin resistance in TNBC through the use of dual-targeted TrxR and DNA Pt(IV) prodrugs, thereby offering a new approach to treating TNBC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ProdrugsFerroptosisTriple Negative Breast NeoplasmsAntineoplastic AgentsImmunogenic Cell DeathThioredoxin-Disulfide ReductaseOrganoplatinum CompoundsHumansAnimalsFemaleMiceCell Line, TumorImmunotherapyCisplatinReactive Oxygen Species

Substanzen

ProdrugsAntineoplastic AgentsThioredoxin-Disulfide ReductaseOrganoplatinum CompoundsCisplatinReactive Oxygen Species

Autor:innen und Institutionen

  • Key Laboratory for Chemistry and Molecular Engineering of Medicinal Resources (Ministry of Education of China), Guangxi Key Laboratory of Chemistry and Molecular Engineering of Medicinal Resources, School of Chemistry a…
  • Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation, Huaiyin Institute of Technology, Huai'an 223003, China.

ORCID-Profile: Hengshan Wang

Förderung

  • Huaiyin Institute of Technology
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region
  • National Natural Science Foundation of China
  • Higher Education Discipline Innovation Project
  • Jiangsu Key Laboratory of Regional Specific Resource Pharmaceutical Transformation

Zitieren

APA

Li, G., Tang, J., Wang, L., Wang, M., Yang, Y., Liu, Z., Wang, H., & Huang, X. (2026). Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.6c00477

Vancouver

Li G, Tang J, Wang L, Wang M, Yang Y, Liu Z, et al. Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast Cancer. Journal of Medicinal Chemistry. 2026. doi:10.1021/acs.jmedchem.6c00477

BibTeX
@article{Li2026,
  author = {Li, Guimei and Tang, Juping and Wang, Lang and Wang, Meng and Yang, Yong and Liu, Zhikun and Wang, Hengshan and Huang, Xiaochao},
  title = {Simultaneous Induction of Ferroptosis and Immunogenic Cell Death by TrxR-Targeted Pt(IV) Prodrugs for Chemoimmunotherapy of Triple-Negative Breast Cancer},
  journal = {Journal of Medicinal Chemistry},
  year = {2026},
  doi = {10.1021/acs.jmedchem.6c00477}
}
Kostenlos starten →